Letter to the editor: Comment on GLP-1-based drugs and COVID-19 treatment.
- Author:
Tianru JIN
1
;
Mingyao LIU
1
Author Information
- Publication Type:Journal Article
- From: Acta Pharmaceutica Sinica B 2020;10(7):1249-1250
- CountryChina
- Language:English
